NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









One-carbon Therapeutics AB

One-carbon Therapeutics AB

Private
SolnaHealthcare & Life Scienceshttps://one-carbon.com/

Last Round

Private Placement

Dec 1, 2025

Total Funding Raised

$1M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

One-carbon Therapeutics AB is a biotechnology company that develops novel anti-cancer therapies targeting the one-carbon metabolic pathway.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyoncologydrug discoverysmall-molecule inhibitorclinical trialsprecision medicinecancer therapymetabolic pathwaysolid tumorsbiotech startupdrug developmentsynthetic lethalitycomputational chemistryclinical-stage biotechpharma pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

One-carbon Therapeutics AB Comparables

Compare One-carbon Therapeutics AB with similar companies based on industry and business-model similarity.

One-carbon Therapeutics AB comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ImmunoMet Therapeutics
78%
Daiichi Sankyo
71%
Tango Therapeutics
69%

One-carbon Therapeutics AB Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementDec 1, 2025
SeedOct 22, 2021

Key People

Founding team and executive leadership

Ana Slipicevic

Chief Executive Officer

Executive Team

One-carbon Therapeutics AB Investors

Notable investors and investment history

One-carbon Therapeutics AB investors
InvestorRounds
Eir VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 6, 2026

    Monthly visitors increased 134% MoM.

  • Feb 25, 2025

    Monthly visitors grew 733% MoM, from 144 to 1.2K.

One-carbon Therapeutics AB Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

One-carbon Therapeutics AB Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about One-carbon Therapeutics AB's valuation, stock price, and market status.

Firmographic Details

HeadquartersSolna
Employee Range5
Year Founded2020
Last FundingDec 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.